Apyx Medical Corporation
Last updated September 27, 2026
Organization details
- Legal name
- Apyx Medical Corporation
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- APYX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000719135
Board of directors
-
Andrew Makrides · DirectorSince 2023
-
Charles D. Goodwin II · Director · Chief Executive OfficerSince 2023
-
Craig A. Swandal · DirectorSince 2023
-
John C. Andres · DirectorSince 2023
-
Lawrence Waldman · DirectorSince 2023
-
Michael Geraghty · DirectorSince 2023
-
Minnie Baylor-Henry · DirectorSince 2023
-
Stavros G. Vizirgianakis · DirectorSince 2024
-
Wendy Lauren Levine · DirectorSince 2023
Chief executives
Charles D. Goodwin II
· Chief Executive Officer
Dates unknown
Board connections
3 of this board's directors also sit on 4 other boards.
- via Lawrence Waldman
- via Lawrence Waldman
- via Minnie Baylor-Henry
- via Stavros G. Vizirgianakis
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2023 | HILL MATTHEW C Officer (Chief Financial Officer) | Open-market purchase | +2,500 | $2.19 | $5,475 |
| Nov 14, 2023 | Charles D. Goodwin II Director, Officer (Chief Executive Officer) | Open-market purchase | +50,000 | $1.57 | $78,500 |
| Jul 12, 2023 | Lawrence Waldman Director | Option exercise | +5,338 | $2.97 | $15,854 |
| Jun 26, 2023 | Hornsby Todd Officer (Executive Vice President) | Option exercise | +15,000 | $1.77 | $26,550 |
| Jun 26, 2023 | Hornsby Todd Officer (Executive Vice President) | Open-market sale | −15,000 | $7.56 | $113,400 |
| Jun 6, 2023 | Michael Geraghty Director | Option exercise | +10,000 | $2.79 | $27,900 |
| Jan 7, 2022 | Craig A. Swandal Director | Option exercise | +7,173 | $9.42 | $67,570 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.